𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Worsening of myasthenia gravis with timolol maleate eyedrops

✍ Scribed by A. Verkijk


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
225 KB
Volume
17
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


natural history of diabetic neuropathy. If sensory and autonomic features of diabetic neuropathy prove to be substantially irreversible-no clinical improvement was seen in the most recent trial of tight glucose control undertaken at the Mayo Clinic (F. J. Service et al)-much more attention will have to be paid to the prevention of neuropathy. This will include the identification of particular risk (and protective) factors. Still to be explained is why some persons, despite persistently poor control, fail to develop neuropathy, while others, with better glycemic control, fare less well. But that is for the future.


πŸ“œ SIMILAR VOLUMES


Long-term treatment of myasthenia gravis
✍ Martin Haas; Norbert Mayr; Josef Zeitlhofer; Andreas Goldammer; Kurt Derfler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

Acute treatment of myasthenic crisis with immunoadsorption (IA) or plasma exchange is well established. The efficiency of chronic apheresis therapy in myasthenia gravis (MG), however, and its efficacy in reducing concomitant potentially harmful immunosuppressive therapy, is unknown. We treated 13 pa

Quality of life in patients with myasthe
✍ L. Padua; A. Evoli; I. Aprile; P. Caliandro; P. D'Amico; A. Rabini; P. Tonali πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views
Treatment of myasthenia gravis with myco
✍ Matthew N. Meriggioli; Julie Rowin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 3 views

We report a patient with myasthenia gravis (MG) who had marked clinical benefit in response to treatment with mycophenolate mofetil as documented by serial quantitative measures of strength and muscle fatigue. Our patient had experienced either adverse side effects or a suboptimal response to the us

Successful treatment of MuSK antibody–po
✍ Berit Hain; Karin Jordan; Marcus Deschauer; Stephan Zierz πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Abstract We report on a 56‐year‐old woman with muscle‐specific receptor tyrosine kinase (MuSK) antibody–positive myasthenia with predominant bulbar symptoms and respiratory insufficiency. Conventional immunosuppression (prednisolone, azathioprine, mycophenolate mofetil) could not maintain the cl